Showing 25 to 36 of 52 results
Successful Gene Editing Therapy Treats Rare Genetic Disorder in Baby
A baby with CPS1 deficiency, a rare genetic disease affecting approximately one in a million infants, successfully underwent a custom gene-editing therapy using base editing, resulting in significant improvement in his health within months.
Successful Gene Editing Therapy Treats Rare Genetic Disorder in Baby
A baby with CPS1 deficiency, a rare genetic disease affecting approximately one in a million infants, successfully underwent a custom gene-editing therapy using base editing, resulting in significant improvement in his health within months.
Progress
40% Bias Score
Gene Editing Therapy Shows Promise in Treating Rare Genetic Disorder
Nine-month-old KJ Muldoon, diagnosed with severe CPS1 deficiency, a rare genetic disorder affecting one in a million babies, is thriving after receiving a custom CRISPR-based gene editing therapy developed in six months by researchers at Children's Hospital of Philadelphia and Penn Medicine.
Gene Editing Therapy Shows Promise in Treating Rare Genetic Disorder
Nine-month-old KJ Muldoon, diagnosed with severe CPS1 deficiency, a rare genetic disorder affecting one in a million babies, is thriving after receiving a custom CRISPR-based gene editing therapy developed in six months by researchers at Children's Hospital of Philadelphia and Penn Medicine.
Progress
40% Bias Score
Superpower Launches $30M Health Super-App for Proactive Healthcare
Superpower launched a health super-app with a $30 million Series A funding round, offering comprehensive biomarker testing for $499/year, aiming to provide proactive healthcare and personalized protocols based on over 100 blood biomarkers.
Superpower Launches $30M Health Super-App for Proactive Healthcare
Superpower launched a health super-app with a $30 million Series A funding round, offering comprehensive biomarker testing for $499/year, aiming to provide proactive healthcare and personalized protocols based on over 100 blood biomarkers.
Progress
60% Bias Score
AI System scNET Improves Understanding of Cellular Drug Response
Tel Aviv University researchers developed scNET, an AI system that analyzes single-cell gene activity and interactions to reveal subtle changes in how cells respond to drug treatments, especially in cancer, as published in Nature Methods.
AI System scNET Improves Understanding of Cellular Drug Response
Tel Aviv University researchers developed scNET, an AI system that analyzes single-cell gene activity and interactions to reveal subtle changes in how cells respond to drug treatments, especially in cancer, as published in Nature Methods.
Progress
24% Bias Score
3D-Printed Medication Improves Pediatric Cancer Treatment
A research team at Hamburg-Ependorf University Hospital uses a 3D printer to create customized, palatable medication for children undergoing cancer treatment, improving adherence and solving dosage problems; the study runs until 2026.
3D-Printed Medication Improves Pediatric Cancer Treatment
A research team at Hamburg-Ependorf University Hospital uses a 3D printer to create customized, palatable medication for children undergoing cancer treatment, improving adherence and solving dosage problems; the study runs until 2026.
Progress
48% Bias Score
Single Genetic Variation Found to Protect Against Type 1 Diabetes
Dutch researchers discovered a single-letter genetic variation protecting against type 1 diabetes, affecting 100,000 people in the Netherlands; this discovery, published in Cell, enables more precise diagnoses, improved disease prediction, and potential new treatments.
Single Genetic Variation Found to Protect Against Type 1 Diabetes
Dutch researchers discovered a single-letter genetic variation protecting against type 1 diabetes, affecting 100,000 people in the Netherlands; this discovery, published in Cell, enables more precise diagnoses, improved disease prediction, and potential new treatments.
Progress
28% Bias Score
Gene Editing Therapy Shows Promise for Rare Genetic Disorder
A nine-and-a-half-month-old baby in Pennsylvania with severe CPS1 deficiency, a rare genetic disorder affecting roughly one in a million infants, is thriving after receiving a custom-designed gene editing therapy using CRISPR base editing, offering hope for millions with rare genetic diseases.
Gene Editing Therapy Shows Promise for Rare Genetic Disorder
A nine-and-a-half-month-old baby in Pennsylvania with severe CPS1 deficiency, a rare genetic disorder affecting roughly one in a million infants, is thriving after receiving a custom-designed gene editing therapy using CRISPR base editing, offering hope for millions with rare genetic diseases.
Progress
32% Bias Score
World-First CAR-T Therapy Success in Treating Anti-MD5 Dermatomyositis
Hospital Universitario La Paz successfully treated a child with anti-MD5 dermatomyositis, a rare autoimmune disease with high mortality, using CAR-T cell therapy (ARI-0001) for the first time globally, resulting in remission after one year and highlighting the therapy's potential for treating other ...
World-First CAR-T Therapy Success in Treating Anti-MD5 Dermatomyositis
Hospital Universitario La Paz successfully treated a child with anti-MD5 dermatomyositis, a rare autoimmune disease with high mortality, using CAR-T cell therapy (ARI-0001) for the first time globally, resulting in remission after one year and highlighting the therapy's potential for treating other ...
Progress
44% Bias Score
NHS to Introduce AI-Powered Personalized Health MOTs for Elderly Patients
The UK's NHS plans to introduce personalized health MOTs using AI and genetic data for frail patients over 65, aiming to improve diagnoses, treatments, and preventative care, potentially saving over \£1 million annually in compensation for missed fractures.
NHS to Introduce AI-Powered Personalized Health MOTs for Elderly Patients
The UK's NHS plans to introduce personalized health MOTs using AI and genetic data for frail patients over 65, aiming to improve diagnoses, treatments, and preventative care, potentially saving over \£1 million annually in compensation for missed fractures.
Progress
48% Bias Score
23andMe's Bankruptcy Filing Raises Privacy Concerns Over Genetic Data
23andMe, a genetic testing company with 15 million customers, filed for Chapter 11 bankruptcy on March 23, prompting privacy concerns about its vast genetic data, which is valuable for marketing and medical research, despite existing legal protections like the Genetic Information Nondiscrimination A...
23andMe's Bankruptcy Filing Raises Privacy Concerns Over Genetic Data
23andMe, a genetic testing company with 15 million customers, filed for Chapter 11 bankruptcy on March 23, prompting privacy concerns about its vast genetic data, which is valuable for marketing and medical research, despite existing legal protections like the Genetic Information Nondiscrimination A...
Progress
28% Bias Score
Single Genetic Variation Holds Key to Type 1 Diabetes Prevention and Treatment
Dutch researchers discovered a single genetic letter variation protecting against type 1 diabetes, affecting 100,000 people, enabling more precise diagnosis, prediction, and potential new treatments using CRISPR-Cas technology; the research is published in Cell.
Single Genetic Variation Holds Key to Type 1 Diabetes Prevention and Treatment
Dutch researchers discovered a single genetic letter variation protecting against type 1 diabetes, affecting 100,000 people, enabling more precise diagnosis, prediction, and potential new treatments using CRISPR-Cas technology; the research is published in Cell.
Progress
28% Bias Score
AI Revolutionizes Healthcare: Continuous Monitoring, Personalized Medicine, and Reshaped Practices
AI-driven wearables and multimodal data analysis are revolutionizing healthcare, enabling 24/7 vital signs monitoring, early disease detection, personalized medicine, and increased accessibility, while reshaping medical practices and training.
AI Revolutionizes Healthcare: Continuous Monitoring, Personalized Medicine, and Reshaped Practices
AI-driven wearables and multimodal data analysis are revolutionizing healthcare, enabling 24/7 vital signs monitoring, early disease detection, personalized medicine, and increased accessibility, while reshaping medical practices and training.
Progress
56% Bias Score
Showing 25 to 36 of 52 results